Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Iressa approved in Japan in new lung cancer indication

Nov. 25, 2011

U.S. university team prepares new ether-based compounds

Nov. 25, 2011

New CYP17 inhibitors for cancer disclosed by Bristol-Myers Squibb

Nov. 25, 2011

Researchers at Deciphera Pharmaceuticals present novel tyrosine-protein kinase inhibitors

Nov. 25, 2011

Additional dosage and indication approved for Herceptin in Japan

Nov. 25, 2011

Preclinical and clinical results reported for Myrexis oncolytic compounds

Nov. 25, 2011

Melphalan flufenamide evaluated in phase I/IIa study

Nov. 25, 2011

Aeterna Zentaris licenses anticancer agent to Hikma

Nov. 24, 2011

Amgen tests antibody-drug conjugate targeting EGFRvIII

Nov. 24, 2011

Updated results presented from ongoing first-in-patient trial of PF-04691502

Nov. 24, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026